| 发明名称 |
METHOD OF COMBINATION THERAPY USING AN ANTI-C-MET ANTIBODY |
| 摘要 |
A method for prevention or treatment of a cancer, comprising co-administering (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib or a combination thereof, to a subject in need thereof, and a pharmaceutical composition comprising (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib, or a combination thereof are provided. |
| 申请公布号 |
US2015140014(A1) |
申请公布日期 |
2015.05.21 |
| 申请号 |
US201314081886 |
申请日期 |
2013.11.15 |
| 申请人 |
Samsung Electronics Co., Ltd. |
发明人 |
LEE Seung Hyun;Kim Geun Woong;Kim Kyung Ah;Park Hye Won;Song Ho Yeong;Oh Young Mi;Lee Saet Byoul;Lee Ji Min;Cheong Kwang Ho;Jeong Yun Ju;Cho Mi Young;Choi Jae Hyun;Song Yun Jeong;Choi Yoon Aa |
| 分类号 |
C07K14/71;A61K31/437;A61K31/44;A61K39/395;A61K31/517 |
主分类号 |
C07K14/71 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for prevention or treatment of a cancer, comprising co-administering (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib or a combination thereof, to a subject in need of prevention or treatment of the cancer. |
| 地址 |
Suwon-si KR |
